CDER is now prioritizing review of generic drug products for which there is only one approved drug product on the market. On March 11, 2016, the Center for Drug Evaluation and Research (CDER) released ...

This brings the total of biosimilars approved by the agency to 45. CDER also details in the report initiatives taken to create efficiencies in its review process. The center met or exceeded its ...